Embolization Agents Market Overview and Forecast Analysi up to 2028 – The Insight Partners.

Posted by niket gore on July 21st, 2022

The embolizationagents’market is projected to reach US$ 24,525.75 million by 2028 from US$ 2,714.82 million in 2021; it is expected to grow at a CAGR of 7.6% from 2021 to 2028. The growth of the market is primarily attributed to the rising incidence of tumors and aneurysms and growing prevalence of hypertension, obesity, smoking, and alcoholism. Moreover, technological advancements in embolization products and procedures are expected to foster the market growth during the forecast period. However, the high costs of embolization agents hinder the market growth. The medical practices worldwide continue to adapt to the challenges of the COVID-19 outbreak. Pandemic has been challenging the already overburdened and underfunded public healthcare systems of South and Central America. With a vast population living in poverty, the countries in the region continuously face widespread health problems due to overcrowding, limited sanitation, food insecurity, and unpredictable environmental conditions. In this scenario, Brazil observed enormous difficulties in the management of cancer surgeries such as head and neck cancer surgeries, chronic neurological disorders such as brain aneurysms, from headache to neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments because of the decompensation of their cancer and neurological disease, thus limiting the embolization agents market growth.


Get Sample Pdf:- https://www.theinsightpartners.com/sample/TIPRE00025058/

The developments in the embolization agents market have been characterized as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as launches, expansion, enhancement as well as relocation. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnership, collaborations, alliance, and agreement & joint ventures. These activities have paved way for expansion of business and customer base of market players

The COVID-19 pandemic has negatively impacted the embolization agents market in North America. The shift of priorities from cardiovascular treatment to COVID-19 diagnosis and treatments is restraining the market growth up to a certain extent. After cardiac surgical procedure, patients require vital ICU resources as well as they may suffer from the highest risk of COVID-19 complications. Hence, many hospitals and surgical centers have decided to cancel or postpone elective surgeries, including cardiovascular surgeries. Therefore, the impact of the COVID-19 pandemic is somewhat negative on the embolization agents market.

Based on application, the embolization agents market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. In 2021, the oncology segment held the largest share of the market. Also,  the market for this segment is expected to grow at the fastest rate during the forecast period.


Embolization Agents Market, by Region, 2021 (%)

Source: The Insight Partners Analysis


The report segments the embolization agents market as follows:

The embolization agents market is segmented on the basis of product, application, and end user. Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. By end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others.

By Geography

North America










Rest of Europe

Asia Pacific (APAC)

Buy Now:- https://www.theinsightpartners.com/buy/TIPRE00025058/





South Korea

Rest of APAC

Middle East and Africa (MEA)

Saudi Arabia


South Africa

Rest of MEA

South and Central America (SCAM)



Rest of SCAM

Reason To Buy: -

  •         Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the embolization agents market.
  •         Highlights key business priorities in order to assist companies to realign their business strategies.
  •         The key findings and recommendations highlight crucial progressive industry trends in the global embolization agents market, thereby allowing players across the value chain to develop effective long-term strategies.
  •         Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  •         Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  •         Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.


List of Companies

  •         Medtronic
  •         Terumo Corporation
  •         Cook Medical LLC
  •         Boston Scientific Corporation
  •         Abbott
  •         Stryker Corporation
  •         Penumbra, Inc.
  •         Merit Medical Systems Inc.
  •         DePuy Synthes

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Like it? Share it!

niket gore

About the Author

niket gore
Joined: July 6th, 2022
Articles Posted: 421

More by this author